Library / Laws / 113th / s / S. 2851 / Introduced in Senate
II
113th CONGRESS
2d Session
S. 2851
IN THE SENATE OF THE UNITED STATES
September 18, 2014Mr. Menendez introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To amend the Public Health Service Act to provide for the expansion, intensification, and
coordination of the programs and activities of the National Institutes of
Health with respect to Tourette syndrome.
1.
Short title
This Act may be cited as the Collaborative Academic Research Efforts for Tourette Syndrome Act of 2014.
2.
Programs of the National Institutes of Health relating to Tourette syndrome
Part B of title IV of the Public Health Service Act is amended by inserting after section 409J (42
U.S.C. 284q) the following:
409K.
Expansion, intensification, and coordination of activities with respect to Tourette syndrome
(a)
In general
The Secretary, acting through the Director of NIH, shall expand, intensify, and coordinate the
programs and activities of the National Institutes of Health with respect
to scientific and clinical research on Tourette syndrome.
(b)
Data collection
(1)
System
In carrying out subsection (a), the Secretary shall develop a system to collect data on Tourette
syndrome, including epidemiologic information with respect to the
incidence, prevalence, and impact of Tourette syndrome in the United
States.
(2)
Broad and narrow definitions
The data collection system under paragraph (1) shall provide for the collection of primary data on
Tourette syndrome, including related data on the various conditions known
to be comorbid with Tourette syndrome.
(3)
Collection by population and geographical region
The data collection system under paragraph (1) shall provide for the collection of data on the
availability of medical and social services for individuals with Tourette
syndrome and their families and the disaggregation of such data by
population and geographical region.
(c)
Collaborative Research Centers for Tourette Syndrome
(1)
In general
In carrying out subsection (a), the Secretary shall award grants and contracts to public or
nonprofit private entities to pay all or part of the cost of planning,
establishing, improving, and providing basic operating support for
Collaborative Research Centers for Tourette Syndrome.
(2)
Research
Each center under paragraph (1) shall conduct basic and clinical research into Tourette syndrome.
Such research should include investigations into the cause, diagnosis,
early detection, prevention, control, and treatment of Tourette syndrome.
The research conducted by such centers, as a group, shall include research
in the fields of developmental neurobiology, neuroscience, genetics,
psychology, and pharmacology.
(3)
Services for patients
(A)
In general
A center under paragraph (1) may expend amounts provided under such paragraph to carry out a
program to make individuals aware of opportunities to participate as
subjects in research conducted by the centers.
(B)
Referral and costs
A program under subparagraph (A) may, in accordance with such criteria as the Secretary may
establish, provide to the subjects described in such subparagraph,
referrals for health and other services, and such patient care costs as
are required for research.
(C)
Availability and access
The extent to which a center can demonstrate availability and access to clinical services shall be
considered by the Secretary in decisions about awarding grants and
contracts to applicants which meet the scientific criteria for funding
under this subsection.
(4)
Organization of Collaborative Research Centers for Tourette Syndrome
(A)
In general
A center under paragraph (1) may—
(i) use the facilities of a single institution; or
(ii) be formed from a consortium of cooperating institutions and patient advocacy groups in order to
maximize the scope of the center’s services and geographic coverage.
(B)
Eligibility requirements
To be eligible to make facilities so available (as described in subparagraph (A)(i)) or participate
in such a consortium (as described in subparagraph (A)(ii)), an
institution or group shall meet such requirements as the Secretary may
prescribe.
(5)
Number of centers; duration of support
(A)
In general
Subject to the availability of appropriations, the Secretary shall provide for the establishment of
not fewer than 4 and not more than 6 centers under paragraph (1).
(B)
Geographical distribution
The Secretary shall—
(i) ensure that each of the centers established under paragraph (1) is located in a different region of
the United States than the other such centers; and
(ii) encourage the formation of such centers from a consortium of entities (as described in paragraph
(4)(A)(ii)) covering multiple regions or States.
(C)
Duration
Support for a center established under paragraph (1) may be provided under this section for a
period of not to exceed 5 years. Such period may be extended for one or
more additional periods not exceeding 5 years if the operations of such
center have been reviewed and approved by an appropriate technical and
scientific peer review group established by the Secretary and if such
group has recommended to the Secretary that such period should be
extended.
(d)
Research on symptomology and treatment
In carrying out subsection (a), the Secretary shall award grants on a competitive, peer-reviewed
basis for research on—
(1) the full range of symptomology within the Tourette syndrome clinical spectrum; and
(2) the efficacy of treatment options for particular patient subpopulations.
(e)
Funding
Of the amounts made available to carry out the programs and activities of the National Institutes
of Health for a fiscal year, the Secretary shall designate a portion of
such amounts for carrying out the programs and activities of the National
Institutes of Health with respect to Tourette syndrome.
.